Eledon Pharmaceuticals (ELDN) Assets Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.08% |
| Dec 31, 2025 | -4.73% |
| Sep 30, 2025 | 13.34% |
| Jun 30, 2025 | 20.27% |
| Mar 31, 2025 | 99.59% |
| Dec 31, 2024 | 99.18% |
| Sep 30, 2024 | 19.26% |
| Jun 30, 2024 | 12.83% |
| Mar 31, 2024 | -1.81% |
| Dec 31, 2023 | -4.02% |
| Sep 30, 2023 | -35.78% |
| Jun 30, 2023 | -30.98% |
| Mar 31, 2023 | -49.00% |
| Dec 31, 2022 | -45.59% |
| Sep 30, 2022 | -15.57% |
| Jun 30, 2022 | -16.06% |
| Mar 31, 2022 | -15.81% |
| Dec 31, 2021 | -13.51% |
| Sep 30, 2021 | -8.00% |
| Jun 30, 2021 | 1,655.12% |
| Mar 31, 2021 | 1,297.10% |
| Dec 31, 2020 | 1,703.91% |
| Sep 30, 2020 | 1,165.51% |
| Jun 30, 2020 | -42.35% |
| Mar 31, 2020 | 2.00% |
| Dec 31, 2019 | -35.80% |
| Sep 30, 2019 | -23.64% |
| Jun 30, 2019 | -20.68% |
| Mar 31, 2019 | -48.10% |
| Dec 31, 2018 | -18.50% |
| Sep 30, 2018 | -13.43% |
| Jun 30, 2018 | -14.45% |
| Mar 31, 2018 | 0.33% |
| Dec 31, 2017 | 1,646.82% |
| Sep 30, 2017 | -37.31% |
| Jun 30, 2017 | -42.71% |
| Mar 31, 2017 | -55.24% |
| Dec 31, 2016 | -98.24% |
| Sep 30, 2016 | -52.68% |
| Jun 30, 2016 | -46.39% |
| Mar 31, 2016 | -40.29% |
| Dec 31, 2015 | -36.91% |
| Sep 30, 2015 | -27.46% |
| Dec 31, 2014 | 233.71% |